Generic Medicine Info
Should be taken with food.
Renal insufficiency or impairment; severe hepatitis.
Special Precautions
Patient with G6PD deficiency. Avoid prolonged use. Not used to treat UTI or as a substitute for antimicrobial therapy (acts only as an analgesic). Discontinue treatment if yellowish skin or sclerae discolouration occurs (may indicate accumulation due to impaired renal excretion). Pregnancy and lactation. Patient Counselling Staining of contact lenses may occur. May also stain fabric or clothing.
Adverse Reactions
Significant: Acute renal failure, hepatotoxicity, methaemoglobinaemia, and haemolytic anaemia (particularly with higher than recommended doses); urine discolouration (reddish-orange), skin or sclerae discolouration (yellow). Gastrointestinal disorders: Stomach cramps, mild gastrointestinal disturbances. Immune system disorders: Anaphylactoid-like reaction. Nervous system disorders: Headache, dizziness. Skin and subcutaneous tissue disorders: Rash, pruritus.
ATC Classification
G04BX06 - phenazopyridine ; Belongs to the class of other urologicals.
Disclaimer: This information is independently developed by CIMS based on phenazopyridine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in